cisapride has been researched along with Cardiovascular Diseases in 2 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The nonselective 5-HT(4) receptor agonists, cisapride and tegaserod have been associated with cardiovascular adverse events (AEs)." | 2.48 | Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. ( Camilleri, M; Chang, L; Chey, WD; De Maeyer, JH; Galligan, JJ; Lacy, BE; Müller-Lissner, S; Quigley, EM; Schuurkes, J; Stanghellini, V; Tack, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tack, J | 1 |
| Camilleri, M | 1 |
| Chang, L | 1 |
| Chey, WD | 1 |
| Galligan, JJ | 1 |
| Lacy, BE | 1 |
| Müller-Lissner, S | 1 |
| Quigley, EM | 1 |
| Schuurkes, J | 1 |
| De Maeyer, JH | 1 |
| Stanghellini, V | 1 |
| Francis, GS | 1 |
2 reviews available for cisapride and Cardiovascular Diseases
| Article | Year |
|---|---|
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.
Topics: Cardiovascular Diseases; Cisapride; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Indo | 2012 |
Cardiac complications in the intensive care unit.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiovascular Diseases; Cisapride; Electrocardiography; Erythr | 1999 |